TRANSFAC DISEASE

Non-profit, One-lab License, 4 seats

Treatments for Complex Clinical Cases with Pathology Unresponsive to Conventional Therapies

Identify drug targets and disease biomarkers.

Automatically process multi-omics raw patient data and identify prospective drug targets and treatments predicted to be effective for the studied clinical case.

Full reconstruction of disease molecular mechanisms
based on the integrated promoter and pathway analysis.

  • Click to expand
  • Click to expand

    • No bioinformatics skills needed
    run complicated omics data processing pipelines from just several clicks in a user-friendly interface.

    What you will get

    • Deep understanding of molecular mechanisms underlying the studied pathology.
    • Prospective treatments suggestions covering both: known and repurposed drugs for the studied pathology in complicated clinical cases where no conventional therapies are effective.
    • Access to the unique MATCH Suite tool for identification of transcription factors regulating the human gene(s) of your interest in the specified conditions.
    • Access to Gene-Disease-Drug-Clinical Trial assignments, disease biomarkers, drug targets, drug-disease approval status, and functional classification tools.
    • Automatically generated comprehensive report fully explaining the performed analysis and the obtained results.
    • Molecular Tumor Board report based on patient’s genomics data supported for a number of neoplasm diseases.

    TRANSFAC Diseases

    Non-profit, One-lab License, 4 seats

      

    -23%

    €5070/year €3900/year + 3 hours of free expert consulting * only for new clients
    • >10,000 PWMs 
    • >1M TF Sites 
    • >200 pipelines  
    • Motif search
    • Site combinations
    • Promoters/Enhancers 
    • Easy GUI 
    • 100GB Cloud Storage 
    • AI and ML
    • API 
    • >1,500 Pathways
    • >1.2M Reactions
    • Master-regulators
    • Upstream analysis
    • SBGN viewer 
    • ODE visual modeling
    • >140,000 Biomarkers 
    • >10,000 Drugs
    • > 55,000 Targets 
    • >1,1M Clinical Trial – Disease links 
    • Drug repurposing 
    • Multi-omics integration 
    • One-click solution
    • Disease mechanism discovery report
    Request now